# Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma

Page: https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma
Text version: https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma.md
Podcast: [Neuro-Oncology: The Podcast](https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653)
Published: 2026-04-13T10:00:00+00:00
Episode link: https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-bivalent-egfril13r2-car-t-cells-for-recurrent-glioblastoma
Audio file: https://traffic.libsyn.com/secure/soc-neuro-onc/nop-127-.mp3?dest-id=2339594
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma
Duration seconds: 149

## Resource

Shahad Abdulsahib discusses a phase 1 clinical trial of intracerebroventricular bivalent EGFR and IL13Rα2 CAR T cells for recurrent glioblastoma, published in Nature Medicine .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.